Skip to content

Drug interactions

Lorlatinib + Praziquantel

Severity: Moderate

Lorlatinib and Praziquantel: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lorlatinib induces CYP3A4 and may reduce praziquantel exposure, risking treatment failure. Praziquantel is only given for a short period, limiting duration of exposure.

What this interaction means in plain words

Lorlatinib and Praziquantel can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lorlatinib belongs to Oncology; Praziquantel belongs to Anti Parasitic.

Evidence level: Low

Why it happens

Lorlatinib induces CYP3A4, increasing praziquantel clearance.

What to do

Monitor for response to praziquantel and consider retreatment if cure is not confirmed. Temporary interruption of lorlatinib is rarely practical, so involve the oncologist.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lorlatinib and Praziquantel, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lorlatinib with Praziquantel?

MediHelp rates the interaction as moderate. Lorlatinib and Praziquantel can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lorlatinib induces CYP3A4 and may reduce praziquantel exposure, risking treatment failure. Praziquantel is only given for a short period, limiting duration of exposure.

How serious is the interaction between Lorlatinib and Praziquantel?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for response to praziquantel and consider retreatment if cure is not confirmed. Temporary interruption of lorlatinib is rarely practical, so involve the oncologist.

What other medicines interact with Praziquantel?

MediHelp also lists interactions of Praziquantel with, for example, Enzalutamide, Rifampin, Amobarbital. The full list is on the Praziquantel page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in